Intracavitary	intracavitary	O	O
chemotherapy	chemotherapy	O	O
(	(	O	O
paclitaxel/carboplatin	paclitaxel/carboplatin	O	O
liquid	liquid	O	O
crystalline	crystalline	O	O
cubic	cubic	O	O
phases	phases	O	O
)	)	O	O
for	for	O	O
recurrent	recurrent	O	O
glioblastoma	glioblastoma	O	S_disease
--	--	O	O
clinical	clinical	O	O
observations	observations	O	O
.	.	O	O

Human	human	O	O
malignant	malignant	O	O
brain	brain	O	O
tumors	tumors	O	S_disease
have	have	O	O
a	a	O	O
poor	poor	O	O
prognosis	prognosis	O	O
in	in	O	O
spite	spite	O	O
of	of	O	O
surgery	surgery	O	O
and	and	O	O
radiation	radiation	O	O
therapy	therapy	O	O
.	.	O	O

Cubic	cubic	O	O
phases	phases	O	O
consist	consist	O	O
of	of	O	O
curved	curved	O	O
biocontinuous	biocontinuous	O	O
lipid	lipid	B_chemical	O
bilayers	bilayers	I_chemical	O
,	,	O	O
separating	separating	O	O
two	two	O	O
congruent	congruent	O	O
networks	networks	O	O
of	of	O	O
water	water	O	O
channels	channels	O	O
.	.	O	O

Used	used	O	O
as	as	O	O
a	a	O	O
host	host	O	O
for	for	O	O
cytotoxic	cytotoxic	O	O
drugs	drugs	O	O
,	,	O	O
the	the	O	O
gel-like	gel-like	O	O
matrix	matrix	O	O
can	can	O	O
easily	easily	O	O
be	be	O	O
applied	applied	O	O
to	to	O	O
the	the	O	O
walls	walls	O	O
of	of	O	O
a	a	O	O
surgical	surgical	O	O
resection	resection	O	O
cavity	cavity	O	O
.	.	O	O

For	for	O	O
human	human	O	O
glioblastoma	glioblastoma	O	S_disease
recurrences	recurrences	O	O
,	,	O	O
the	the	O	O
feasibility	feasibility	O	O
,	,	O	O
safety	safety	O	O
,	,	O	O
and	and	O	O
short-term	short-term	O	O
effects	effects	O	O
of	of	O	O
a	a	O	O
surgical	surgical	O	O
intracavitary	intracavitary	O	O
application	application	O	O
of	of	O	O
paclitaxel	paclitaxel	S_chemical	O
and	and	O	O
carboplatin	carboplatin	S_chemical	O
encapsulated	encapsulated	O	O
by	by	O	O
liquid	liquid	O	O
crystalline	crystalline	O	O
cubic	cubic	O	O
phases	phases	O	O
are	are	O	O
examined	examined	O	O
in	in	O	O
a	a	O	O
pilot	pilot	O	O
study	study	O	O
.	.	O	O

A	a	O	O
total	total	O	O
of	of	O	O
12	12	O	O
patients	patients	O	O
with	with	O	O
a	a	O	O
recurrence	recurrence	O	O
of	of	O	O
a	a	O	O
glioblastoma	glioblastoma	O	S_disease
multiforme	multiforme	O	O
underwent	underwent	O	O
re-resection	re-resection	O	O
and	and	O	O
received	received	O	O
an	an	O	O
intracavitary	intracavitary	O	O
application	application	O	O
of	of	O	O
paclitaxel	paclitaxel	S_chemical	O
and	and	O	O
carboplatin	carboplatin	S_chemical	O
cubic	cubic	O	O
phases	phases	O	O
in	in	O	O
different	different	O	O
dosages	dosages	O	O
.	.	O	O

Six	six	O	O
of	of	O	O
the	the	O	O
patients	patients	O	O
received	received	O	O
more	more	O	O
than	than	O	O
15	15	O	O
mg	mg	O	O
paclitaxel	paclitaxel	S_chemical	O
and	and	O	O
suffered	suffered	O	O
from	from	O	O
moderate	moderate	O	O
to	to	O	O
severe	severe	O	O
brain	brain	O	B_disease
edema	edema	O	S_disease
,	,	O	O
while	while	O	O
the	the	O	O
remaining	remaining	O	O
patients	patients	O	O
received	received	O	O
only	only	O	O
a	a	O	O
total	total	O	O
of	of	O	O
15	15	O	O
mg	mg	O	O
paclitaxel	paclitaxel	S_chemical	O
.	.	O	O

In	in	O	O
the	the	O	O
latter	latter	O	O
group	group	O	O
,	,	O	O
brain	brain	O	B_disease
edema	edema	O	S_disease
was	was	O	O
markedly	markedly	O	O
reduced	reduced	O	O
and	and	O	O
dealt	dealt	O	O
medically	medically	O	O
.	.	O	O

Intracavitary	intracavitary	O	O
chemotherapy	chemotherapy	O	O
in	in	O	O
recurrent	recurrent	O	O
glioblastoma	glioblastoma	O	S_disease
using	using	O	O
cubic	cubic	O	O
phases	phases	O	O
is	is	O	O
feasible	feasible	O	O
and	and	O	O
safe	safe	O	O
,	,	O	O
yet	yet	O	O
the	the	O	O
clinical	clinical	O	O
benefit	benefit	O	O
remains	remains	O	O
to	to	O	O
be	be	O	O
examined	examined	O	O
in	in	O	O
a	a	O	O
clinical	clinical	O	O
phase	phase	O	O
II	ii	O	O
study	study	O	O
.	.	O	O

